4.1 Article

Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis

Journal

CLINICAL OBSTETRICS AND GYNECOLOGY
Volume 61, Issue 2, Pages 260-268

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GRF.0000000000000358

Keywords

vasomotor symptoms; thrombosis; venous thromboembolism; hormone therapy; nonhormonal therapy; genitourinary syndrome of menopause

Funding

  1. TherapeuticsMD

Ask authors/readers for more resources

For women at elevated risk of thrombosis, clinicians are challenged to relieve menopausal symptoms without increasing the risk of thrombosis. Oral menopausal hormone therapy increases the risk of venous thromboembolism by 2-fold to 3-fold. Observational studies suggest less thrombotic risk with transdermal therapies and with progesterone over synthetic progestogens (progestins), but the data are limited. Beneficial nonpharmacologic therapies include cognitive behavioral therapy and clinical hypnosis, whereas beneficial nonhormonal pharmacologic therapies include selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. For treatment of the genitourinary syndrome of menopause, vaginal lubricants and moisturizers, low-dose vaginal estrogen, and intravaginal dehydroepiandrosterone are options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available